AU1769297A - Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology - Google Patents

Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology

Info

Publication number
AU1769297A
AU1769297A AU17692/97A AU1769297A AU1769297A AU 1769297 A AU1769297 A AU 1769297A AU 17692/97 A AU17692/97 A AU 17692/97A AU 1769297 A AU1769297 A AU 1769297A AU 1769297 A AU1769297 A AU 1769297A
Authority
AU
Australia
Prior art keywords
pharmaceutical agents
metal complexes
interventional radiology
tumour therapy
agents containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17692/97A
Other languages
English (en)
Inventor
Thomas Frenzel
Ulrich Niedballa
Johannes Dr. Platzek
Bernd Dr. Raduchel
Wolfgang Schlecker
Hanns-Joachim Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU1769297A publication Critical patent/AU1769297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU17692/97A 1996-02-23 1997-02-14 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology Abandoned AU1769297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19608278 1996-02-23
DE19608278A DE19608278A1 (de) 1996-02-23 1996-02-23 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
PCT/EP1997/000684 WO1997030969A1 (de) 1996-02-23 1997-02-14 Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie

Publications (1)

Publication Number Publication Date
AU1769297A true AU1769297A (en) 1997-09-10

Family

ID=7787153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17692/97A Abandoned AU1769297A (en) 1996-02-23 1997-02-14 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology

Country Status (14)

Country Link
EP (1) EP0882010B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000504736A (cg-RX-API-DMAC7.html)
AT (1) ATE200894T1 (cg-RX-API-DMAC7.html)
AU (1) AU1769297A (cg-RX-API-DMAC7.html)
CA (1) CA2247253A1 (cg-RX-API-DMAC7.html)
DE (2) DE19608278A1 (cg-RX-API-DMAC7.html)
DK (1) DK0882010T3 (cg-RX-API-DMAC7.html)
ES (1) ES2158493T3 (cg-RX-API-DMAC7.html)
GR (1) GR3036306T3 (cg-RX-API-DMAC7.html)
NO (1) NO323547B1 (cg-RX-API-DMAC7.html)
PT (1) PT882010E (cg-RX-API-DMAC7.html)
TW (1) TW477699B (cg-RX-API-DMAC7.html)
WO (1) WO1997030969A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA971537B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919433A (en) * 1996-12-04 1999-07-06 Schering Aktiengesellschaft Macrocyclic metal complex carboxylic acids, their use as well as process for their production
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
CN1279893C (zh) * 2001-08-03 2006-10-18 葛兰素集团有限公司 表面活性剂化合物及其用途
AU2003249999A1 (en) * 2002-07-10 2004-02-02 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
DE102005008309A1 (de) * 2005-02-17 2006-08-24 Schering Ag Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone
ITMI20131225A1 (it) * 2013-07-22 2015-01-23 Miteni Spa Nuovi composti organici fluorurati, procedimento per la loro preparazione e loro uso come intermedi di sintesi
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
IL321215B2 (en) 2018-11-23 2026-05-01 Bayer Ag Contrast media formulation and process for its preparation
JP2024020674A (ja) * 2021-01-06 2024-02-15 Agc株式会社 ペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803869C2 (de) * 1978-01-30 1983-12-29 Ethicon, Inc., 08876 Somerville, N.J. Injizierbare Embolisations- und Okklusionslösung
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JP2657393B2 (ja) * 1988-05-18 1997-09-24 日本化薬株式会社 化学塞栓療法剤
FR2682110B1 (fr) * 1991-10-02 1995-05-24 Atta Ligands amphiphiles perfluoroalkyles leurs complexes metalliques et leurs utilisations dans des preparations a usage therapeutique.
EP0673655A1 (en) * 1992-03-19 1995-09-27 Daikin Industries, Limited Mri contrast medium and diagnostic method
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same

Also Published As

Publication number Publication date
GR3036306T3 (en) 2001-10-31
TW477699B (en) 2002-03-01
PT882010E (pt) 2001-10-30
DK0882010T3 (da) 2001-08-20
ATE200894T1 (de) 2001-05-15
ZA971537B (en) 1997-10-30
EP0882010B1 (de) 2001-05-02
WO1997030969A1 (de) 1997-08-28
NO323547B1 (no) 2007-06-11
ES2158493T3 (es) 2001-09-01
NO983875D0 (no) 1998-08-21
NO983875L (no) 1998-10-22
CA2247253A1 (en) 1997-08-28
EP0882010A1 (de) 1998-12-09
DE59703468D1 (de) 2001-06-07
JP2000504736A (ja) 2000-04-18
DE19608278A1 (de) 1997-08-28

Similar Documents

Publication Publication Date Title
GR3036306T3 (en) Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology
ZA975437B (en) New pyridyl alkene and pyridyl alkine acid amides.
AU7305196A (en) Compound on a base of nitrogen monoxide used as a medication
HUP0303665A2 (hu) Káliumcsatorna-blokkoló hatású arilezett furán- és tiofén-karbonsavamidok
GEP20032922B (en) Benzoheterocycles and Their Use as MEK Inhibitors
AU8623698A (en) Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
GB9308957D0 (en) Novel produgs
CA2372563A1 (en) Nickel-poor austenitic steel
EP0696283A1 (en) 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- AND / OR 10- SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
BR9814048A (pt) "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia "
AU3258197A (en) Peptides
EP0486045A3 (en) S(+)-phenyl-alkanoic acids and alpha-amino acid containing complexes
AU562423B2 (en) Benzoic acid derivatives
AU6141494A (en) Hydroxymethyl furazane carboxylic acid derivatives and theiruse in the treatment of cardio-vascular conditions
IL116166A (en) Process for the preparation of 5-amino-2,4,6- triiodoisophthalic acid dichloride
GB8823605D0 (en) Therapeutic agents
KR840004753A (ko) 3-아미노-6-아릴-1,2,4-트리아졸로[4,3-b] 피리다진의 제조방법
WO1998038994A3 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
AU5731386A (en) 99mTc(III) myocardial imaging agents which are non-reducable in vivo
GR3023896T3 (en) 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof.
CA2305764A1 (en) Bile acid salts of metals with physiological action and the use thereof in therapy
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides
Brothers et al. Protein-protein orientation in electron-transfer reactions of the cytochrome c/plastocyanin complex with free cytochrome c and with free plastocyanin
EP0284069A3 (en) Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses